Treatment of melasma with Pycnogenol®

Phytotherapy Research

Volumn 16, Issue 6, 2002, Pages 567-571

  Ni, Z ^a   Mu, Y ^a   Gulati, O ^b  

^a XIYUAN HOSPITAL   (China)

^b Horphag Research   (Switzerland)

Author keywords

Chloasma; Dietary supplement: plant extract; Hyperpigmentation; Melasma; Pycnogenol

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; PINUS PINASTER EXTRACT; PLANT EXTRACT; PYCNOGENOL; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT ACTIVITY; ANXIETY; ARTICLE; BLOOD ANALYSIS; CHLOASMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; HUMAN; HYPERPIGMENTATION; PAIN; PATHOGENESIS; SIDE EFFECT; SUN EXPOSURE; SYMPTOM; ULTRAVIOLET RADIATION; URINALYSIS;

ADULT; FEMALE; FLAVONOIDS; HUMANS; MELANOSIS; MIDDLE AGED; PHYTOTHERAPY; PINUS; PLANT BARK; PLANT EXTRACTS; SKIN PIGMENTATION; SUNSCREENING AGENTS; TREATMENT OUTCOME; ULTRAVIOLET RAYS;

MELASMA; PINUS PINASTER;

EID: 0036743446     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1085     Document Type: Article

References (35)

1. Arcangeli P. 2000. Pycnogenol® I F, in chronic venous insufficiency. Fitoterapia 71: 236-244.
2. Bito T, Roy S, Sen CK, Packer L. 2000. Pine bark extract Pycnogenol down regulates IFN γ-induced adhesion of T cells to human keratinocytes by inhibiting inducible ICAM-1 expression. Free Radic Biol Med 28: 219-227.
3. Blazsó G, Gabor M, Rohdewald P. 1997. Antiinflammatory activities of procyanidin-containing extracts from Pinus pinaster Ait. after oral and cutaneous application. Pharmazie 52: 380-382.
4. Blazsó G, Gábor M, Sibbel R, Rohdewald O. 1994. Anti-inflammatory and superoxide radical scavenging activities of a procyandin containing extract from the bark of Pinus pinaster Sol. and its fractions. Pharm Pharmacol Lett 3: 217-220.
5. Chida M, Suzuki K, Nakanishi-Ueda T et al. 1999. In vitro testing of antioxidants and biochemical end-points in bovine retinal tissue. Ophthal Res 31: 407-415.
6. Cho KJ, Yoon DY, Cho YS, Rimbach G, Packer L, Chung AS. 2000. Effect of bioflavonoid extract from the bark of Pinus maritime on pro-inflammatory cytokine interleukin production in lipopolysaccharide-stimulated RAW 264.7. Toxicol Appl Pharmaco 168: 64-71.
7. Cossins E, Lee R, Packer L. 1998. ESR studies of vitamin C regeneration, order of reactivity of natural source of phytochemical preparations. Biochem Mol Biol Int 45: 583-597.
8. Cotellessa C, Peris K, Onorati MT, Fargnoli MC, Chmenti S. 1999. The use of chemical peeling in the treatment of different cutaneous hyperpigmentations. Dermatol Surg 25:450-454.
9. Cunningham ML, Krinsky NI, Giovanazzi SM, Peak MJ. 1985. Superoxide anion is generated from cellular metabolites by solar radiation and its components. Free Rad Biol Med 1: 381-385.
10. Fitzpatrick, DF, Bing B. 1998. Endothelium dependent vascular effects of Pycnogenol. J Cardiovasc Pharmacol 32: 509-515.
11. Fitzpatrick RE, Goldman MP, Ruiz-Esparza J. 1993. Laser treatment of benign pigmented epidermal lesions using a 300- nsecond pulse and 510 nm-wavelength. J Dermatol Surg Oncol 18: 341-347.
12. Gabor M, Engi M, Sonkodi S. 1993. Die Kapillarwandresistenz und ihre Beein flussung durch wasserl6sliche Flavonderivate bei spontan hypertonschen Ratten. Phelebologie 22: 178-182.
13. Goh CL, Dlova CN. 1999. A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral center in Singapore. Singapore Med J 40: 455-458.
14. Grekin RC, Shelton RM, Geisse JK, Frieden I. 1993. 510 -nm pigmented lesion dye laser: its characteristics and clinical uses. J Dermatol Surg Oncol 19: 380-387.
15. Griffiths CE, Finkel LJ, Ditre CM, Hamilton TA, Ellis CN, Voorhees JJ 1993. Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled clinical trial. Br J Dermatol 129: 415-421.
16. Grimes PE. 1995. Melasma etiological and therapeutic considerations. Arch Dermatol 131: 1453-1457.
17. Guochang Z. 1993. Ultraviolet radiation induced oxidative stress in cultured human skin fibroblast and antioxidant protection, Biol Res Rep Uni Jyvaskyla 33: 1-86,
18. Hattori Y, Nishigori C, Tanaka T et al. 1996. 8-hydroxy-2′-deoxyguanosine is increased in epidermal cells of hairless mice after chronic ultraviolet B exposure. J Invest Dermatol 107: 733-737.
19. Hayakawa R, Ueda H, Nozaki T et al. 1981. Effects of combination treatment with vitamins E and C on chloasma and pigmented contact dermatitis. A double blind controlled clinical trial. Acta Vitaminol Enzymol 3: 31-38.
20. Hruza LL, Pentland AP. 1993. Mechanisms of UV-induced inflammation J Invest Dermatol 100: 35S-41S.
21. Kauh Y, Zachian TF. 1999. Melasma. Adv Exp Med Biol 455: 491-499.
22. Moy LS, Murad H, Moy RL. 1993. Glycolic acid peels for the treatment of wrinkles and photoaging. J Dermatol Surg Oncol19:240-243.
23. Muzaffar F, Hussain I, Haroon TS. 1998. Physiological skin changes during pregnancy: a study of 140 cases. Int J Dermatol 37: 429-431.
24. Noda Y, Anzai K, Mori A, Kohno M, Shinmei M, Packer L. 1997. Hydroxyl and superoxide anion radical scavenging activities of natural source antioxidants using the computerized JES-FR30 ESR spectrometer system. Biochem Mol Biol Interen 42: 35-44.
25. Packer L, Rimbach G, Virgili F. 1999. Antioxidant activity and biologic properties of a procyanid-rich extract from the pine (Pinus maritime) bark, Pycnogenol. R Free Rad Biol Med 27: 704-724.
26. Pathak MA, Fitzpatrick TB, Kraus EW. 1986. Usefulness of retinoic acid in the treatment of melasma. J Am Acad Dermatol 15: 894-899.
27. Petrassi C, Mastromarino A, Spartera C. 2000. Pycnogeno® in chronic venous insufficiency. Phytomedicine 7: 383-388.
28. Pütter, M, Grotemeyer KHM, Würthwein G, Araghi-Niknam M, Watson RR. 1999. Inhibition of smoking-induced platelet aggregation by aspirin and Pycnogenol. Thrombosis Res 95: 155-161.
29. Rihn B, Saliou C, Bottin MR, Packer L. 2001. From ancient remedies to modern therapeutics: Pine bark uses in skin disorders revisited. Phytother Res 15: 76-78.
30. Rohdewald P. 1998. Pycnogenol. In Flavonoids in Health and Disease Rice Evans CA, Packer L.(eds). Dekker Inc: 405-419.
31. Saliou C, Rimbach G, Moini H et al. 2001. Solar ultraviolet-induced erythema in human skin and nuclear factor-kappa-B-dependent gene expression in keratinocytes are modulated by a French maritime pine bark extract. Free Rad Biol Med 30: 154-160.
32. Sanchez NP, Pathak MZ, Fitzpatrick TB, Sanchez JL, Mihm MC. 1981. Melasma. J Am Acad Dermatol 4: 698-710.
33. Spadea L, Balestrazzi E. 2001. Treatment of vascular retinopathies with Pycnogenol®. Phytother Res 15: 219-223.
34. Teijun, Z. Guang, Z. Shuyan Z et al. 1996. Pigmentary Dermatosis, 91-92.
35. Wang S, Tan D, Zhao Y, Gao G, Hu L. 1999. The effect of Pycnogenol on the microcirculation, platelet function and ischemic myocardium in patients with coronary artery diseases. Eur Bull Drug Res 7 (2): 19-24.